OSE Immunotherapeutics SA
LSE:0RAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OSE Immunotherapeutics SA
LSE:0RAD
|
FR |
|
G
|
GMK Noril'skiy Nikel' PAO
VSE:MNOD
|
RU |
|
T
|
Telefonaktiebolaget LM Ericsson
DUS:ERCB
|
SE |
|
Bridgestone Corp
F:BGT
|
JP |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
CA |
|
Z
|
Zijin Mining Group Co Ltd
XMUN:FJZ
|
CN |
|
R
|
Rhoen Klinikum AG
DUS:RHK
|
DE |
|
Nippon Television Holdings Inc
F:NP9
|
JP |
Dividends
Dividend Yield
OSE Immunotherapeutics SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
OSE Immunotherapeutics SA
0RAD have decreased by 0%.
Payout Ratio
OSE Immunotherapeutics SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0RAD is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0RAD Price
OSE Immunotherapeutics SA
| Average Annual Return | -16.52% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -76% |
| Market Capitalization | 70.5m EUR |
| Shares Outstanding | 75 515 |
| Percentage of Shares Shorted |
N/A
|
